Today: 20 May 2026
S&P Global stock price rises 3% into holiday weekend as insider buy hits tape
15 February 2026
1 min read

S&P Global stock price rises 3% into holiday weekend as insider buy hits tape

New York, February 14, 2026, 19:38 EST — Market’s done for the day.

S&P Global Inc. finished Friday up 3.11% at $409.54, marking a second consecutive gain and easily beating the broader market, which was little changed. About 4.7 million shares changed hands—close to twice the 50-day average. Moody’s picked up 2.73%, while MSCI climbed 1.13%.

After a rough February rout, the sector is clawing back some ground. Investors had been unloading chunks of the software-and-data universe, spooked by worries that rapid-fire AI innovation could eat into established players’ pricing muscle. S&P Global? Down over 25% since the start of the month, Reuters noted—heading for its sharpest monthly decline since 2009. Barclays’ Emmanual Cau summed up the mood: “sell first think later.” Reuters

Hubert Joly, a board member, snapped up 2,500 shares at roughly $399 apiece on Feb. 11, stepping in close to the recent lows, according to a Form 4 filing. U.S. markets approach a shortened week with Wall Street shut down Monday for Presidents Day.

The action on Friday mirrored a swing in rates, as Treasury yields declined following January’s U.S. consumer price data. Prices rose 2.4% from a year earlier—softer than the 2.5% jump forecast by a Reuters poll. “A bit of good news as we head into the long holiday weekend,” said Tim Holland at Orion. Reuters

Since dropping its 2026 outlook along with quarterly numbers earlier this week, S&P Global has been moving to recalibrate Wall Street’s expectations. The firm put out a forecast for adjusted diluted earnings per share between $19.40 and $19.65 for 2026, plus organic constant-currency revenue growth pegged at 6% to 8%. “We delivered a strong quarter driven by performance in all divisions,” CEO Martina Cheung said. SEC

These figures are crucial: segments of S&P Global’s business depend directly on market swings. Ratings transaction revenue moves in step with debt issuance, and the index division’s fortunes are hitched to the volume of assets following its benchmarks, plus trading in related exchange-traded derivatives.

Friday’s jump doesn’t put to rest the broader questions about AI disruption risks for data-centric firms. Should clients start cutting back on subscriptions or if bond issuance loses steam, the stock’s valuation may come under renewed scrutiny — and another wave of AI-fueled negative sentiment could drag the group back down.

Markets are waiting on several key economic updates once trading gets underway again. The Federal Reserve’s meeting minutes land Wednesday, Feb. 18. Then, on Friday, Feb. 20, S&P Global releases “flash” PMI numbers—a preliminary snapshot of business activity—alongside U.S. advance fourth-quarter GDP and the core PCE price index, which the Fed watches closely for inflation signals. spglobal.com

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Procter & Gamble stock price: PG shares slip as Italy ad probe and insider sale set up a key week
Previous Story

Procter & Gamble stock price: PG shares slip as Italy ad probe and insider sale set up a key week

Micron stock price in focus as India start-up timeline lands on a US market holiday
Next Story

Micron stock price in focus as India start-up timeline lands on a US market holiday

Go toTop